Microline PENTAX Acquires Starion Instruments

Provides global access to Starion’s Tissue Welding technology and expands Microline PENTAX’s reach into new surgical markets.

Microline PENTAX, a leading manufacturer of reposable instruments for minimally invasive surgery, announced today that it has acquired Starion Instruments™ Corp., a privately held developer of surgical technology for sealing and dividing soft tissue. The acquisition provides Microline with an innovative product line that is complementary to its own and marks the company’s first foray into the cardiology and Ear Nose & Throat (ENT) markets.

“Starion’s technology is a strategic fit for our company since it enables us to offer surgeons and their patients an innovative tool in laparoscopy that perfectly complements our reposable product line; as a result, our expanded product portfolio will better address current and future procedure needs,” said Dr. Jean-Luc Boulnois, Chairman, President and Chief Executive Officer of Microline. “Furthermore, this acquisition presents the opportunity for us to grow our business within existing markets and simultaneously expand into new markets where Starion has experienced success to date.”

Headquartered in Beverly, Massachusetts, Microline PENTAX designs, develops, manufactures and markets a broad range of minimally invasive reposable surgical instruments that offer high quality and precision, combined with ease of use and affordability. Microline is a wholly owned subsidiary of HOYA Corporation in Tokyo, Japan, a $4.5 billion company with approximately half of its revenues from medical business including endoscopy and eye care. This acquisition will provide surgeons worldwide with access to Starion Instruments’ full line of advanced surgical devices and furthers HOYA’s strategy of building a minimally invasive surgical franchise on a global scale.

“Surgeons in the U.S. and abroad have been extremely receptive to Starion’s technology and we are very pleased to have the opportunity to expand its reach as part of Microline,” said Kirt Kirtland, President and Chief Executive Officer of Starion Instruments. “Microline’s leadership position in the field of laparoscopy, combined with its strong international presence, will provide valuable resources for existing and future users of Starion’s products.”

Headquartered in Sunnyvale, California, Starion Instruments develops innovative products for laparoscopic and open surgery using simple yet highly effective technologies. Unlike conventional products employing monopolar, bipolar or ultrasonic energy, Starion’s products feature the company’s patented Tissue Welding technology, which uses direct heat and pressure to simultaneously seal and divide soft tissue and vessels. Because no electrical energy is required to pass through the patient, Starion’s products minimize the risk of collateral tissue damage and provide a safe, effective and reliable solution to a broad range of cardiac, gynecological, general surgical, otolaryngologic and urologic procedures.

“Starion’s versatile technology provides an innovative approach to tissue sealing and cutting that can be integrated into a variety of platforms, such as Single Port Access surgery today, and perhaps, flexible endosurgery in the future” said Sharad Joshi, newly appointed President and Chief Operating Officer of Starion Instruments. “This presents significant growth opportunities in the field of minimally invasive surgery.”

The financial terms of the agreement were not disclosed.

Source:  Microline PENTAX

Share your thoughts

Your email address will not be published.